Paper Details

  1. Home
  2. Paper Details

Gender and triptan efficacy: a pooled analysis of three double-blind, randomized, crossover, multicenter, Italian studies comparing frovatriptan vs. other triptans.

Author: AllaisGianni, BenedettoChiara, BussoneGennaro, CampesiIlaria, FinocchiCinzia, FranconiFlavia, OmboniStefano, ReggiardoGiorgio, TulloVincenzo

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This pooled analysis of three randomized studies assessed the efficacy of frovatriptan versus other triptans in treating migraine, considering gender differences. Frovatriptan showed similar efficacy in both men and women, with a lower rate of relapse compared to other triptans, regardless of gender.
Paper Details　
Original Abstract of the Article :
Migraine is three times as common in females as in males, and attacks may be more severe and difficult to treat in women. However, no study specifically addressed possible gender differences in response to antimigraine therapy. The objective of this study was to review the efficacy of frovatriptan v...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035544/

データ提供：米国国立医学図書館（NLM）

Frovatriptan: A Potential Treatment for Migraine Regardless of Gender

Migraine is a common neurological condition that affects millions worldwide. This study investigates the efficacy of frovatriptan, a triptan medication, in the treatment of migraine, specifically examining possible gender differences in response to therapy. The researchers conducted a pooled analysis of three randomized, double-blind, crossover studies comparing frovatriptan to other triptans. The study found that frovatriptan was equally effective in both men and women, providing pain relief and reducing the risk of migraine relapse.

Frovatriptan: Effective Migraine Treatment for Both Men and Women

This study provides compelling evidence for the efficacy of frovatriptan in treating migraine headaches, regardless of gender. The researchers found that frovatriptan was equally effective in both men and women, providing pain relief and reducing the risk of migraine relapse. This finding suggests that frovatriptan can be a valuable treatment option for migraine sufferers, regardless of their gender.

Gender-Specific Considerations in Migraine Treatment

This research underscores the importance of considering gender in migraine treatment. While the study found that frovatriptan was equally effective in both men and women, it highlights the need for ongoing research to further investigate gender-specific differences in migraine response and treatment outcomes. This research contributes to a better understanding of migraine and its management.

Dr.Camel's Conclusion

This research, like a desert traveler finding a universal source of water, highlights the potential of frovatriptan as an effective treatment option for migraine sufferers, regardless of their gender. The study's findings underscore the importance of considering individual needs and preferences in migraine treatment, while also emphasizing the need for continued research to address gender-specific differences in migraine response.
Date :
  1. Date Completed 2015-01-15
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

24867845

DOI: Digital Object Identifier

PMC4035544

Related Literature

Article Analysis
・Effects of almotriptan・Effects of frovatriptan
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.